Global Polymerase Chain Reaction Technologies Market valued approximately USD 8 billion in 2018 is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2019-2026. It is a medical device which is used for genetic engineering, genetics and molecular biology research. Increasing geriatric population, growing diagnostic centers and hospitals, rising prevalence of infectious diseases, advance technologies and increasing awareness personalized medicine are the major factors which drives the market growth. Minimize various PCR processes makes this one less tedious and may open various opportunities for this market. Furthermore, rising in funding for Research & Development activities and presence of major market players in developing countries are expected to provide new opportunity for the market in near future.
The regional analysis of global Polymerase Chain Reaction Technologies market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising disposable income, advance technologies and increasing awareness personalized medicine would create lucrative growth prospects for the Polymerase Chain Reaction Technologies market across Asia-Pacific region.
Major market player included in this report are:
Agilent Technologies, Inc.
Biomeriux S.A
Bio-Rad Laboratories, Inc.,
Hoffmann-La Roche AG(ROCHE)
Fluidigm Corporation
LGC Limited
Qiagen N.V.
Sygnis AG
Tarkara Bio Inc.
Thermo Fisher Scientific Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Real-Time PCR
Traditional PCR
Digital PCR
By Product:
Reagents & Consumers
Instruments
Software
Services
By Application:
Clinical
Researcher
Forensics
By End-Use:
Diagnostics Centre & Hospital
Biotech & Pharma Companies
Academic & Research Institution
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016,2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Polymerase Chain Reaction Technologies Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors